Pasithea Therapeutics annual operating margin
2021
2022
Pasithea Therapeutics's operating margin was −2,587.35% for fiscal 2022.
View full Pasithea Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −2,587.35% | +27338.38 pp |
| 2021 | 2021-12-31 | −29,925.73% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −1,679.52% | — |
| Q3 2022 | 2022-09-30 | −1,763.76% | — |
| Q2 2022 | 2022-06-30 | −19,229.50% | — |
| Q1 2022 | 2022-03-31 | −15,220.95% | — |
Across the available reported history, Pasithea Therapeutics's operating margin increased from −29,925.73% to −2,587.35%, a change of +27338.38 percentage points. The latest reported quarter, Q4 2022, shows −1,679.52%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pasithea Therapeutics filings at SEC.gov ↗